Exploring SGPT/SGOT Ratio Biochemical Marker for “Non-Alcoholic Fatty Liver Disease”

Abstract

Purpose: “Non-Alcoholic Fatty Liver Disease (NAFLD)” is a challenging ailment that has been occurring among adults with 25% global prevalence among adults. The disease, as a liver complication is attributed as a challenging development of other diseases and having a clinical burden. Oftentimes, “Type 2 Diabetes Mellitus” is considered to be related to NAFLD. The following study had focused on implementation of a cross-sectional research and had identified to be involving patients within the age group of 30s to 60s years of age. 200 patients had been selected for the study’s findings, this included both patients diagnosed with and without fatty liver. The SGPT/SGOT ratio was evaluated within the study. The results indicated that the SGPT/SGOT ratio’s mean was 1.34 for 120 out of all 200 patients with fatty liver. As per the results, the SGPT/SGOT ratio was identified as statistically significant. Hence, in conclusion, it is determined that SGPT/SGOT is considered as a biochemical marker for NAFLD incidence during initial stages.